Splenic infarction and bevacizumab.
(2006) The Lancet Oncology — Vol. 7, p. 1038 (2006)
Files
2006_Malka_Lancet_Oncol.pdf
Restricted Access - Adobe PDF
- 89.33 KB
Details
- Authors
- Affiliations
Citations
Malka, D., Van den Eynde, M., Boige, V., Dromain, C., & Ducreux, M. (2006). Splenic infarction and bevacizumab. The Lancet Oncology, 7, 1038. https://doi.org/10.1016/S1470-2045(06)70980-9 (Original work published 2006)